LABORATOIRE 7 MED : revenue, balance sheet and financial ratios

LABORATOIRE 7 MED is a French company founded 28 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in LORIOL-SUR-DROME (26270), this company of category ETI shows in 2023 a revenue of 2.7 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - LABORATOIRE 7 MED (SIREN 412827321)
Indicator 2024 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C 2 721 634 € 4 079 709 € 3 781 611 € 3 506 201 € 2 928 733 € 2 327 346 € 2 227 047 € 2 398 938 €
Net income -307 560 € -200 075 € 626 826 € 172 549 € -46 032 € 274 802 € 90 434 € -263 437 € -766 721 €
EBITDA N/C -561 955 € 98 329 € 195 280 € 6 090 € 312 331 € 78 326 € -129 245 € -92 811 €
Net margin N/C -7.4% 15.4% 4.6% -1.3% 9.4% 3.9% -11.8% -32.0%

Revenue and income statement

In 2024, LABORATOIRE 7 MED records a net loss of 308 k€. This deficit will reduce equity on the balance sheet.

Net income (2024) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

-307 560 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 14%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 57%. This high autonomy means the company finances most of its assets through equity, a sign of strength.

Debt ratio (2024) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

14.049%

Financial autonomy (2024) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

56.665%

Asset age ratio (2024) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

3.8%

Solvency indicators evolution
LABORATOIRE 7 MED

Sector positioning

Debt ratio
14.05 2024
2022
2023
2024
Q1: 1.92
Med: 18.86
Q3: 55.42
Good +8 pts over 3 years

In 2024, the debt ratio of LABORATOIRE 7 MED (14.05) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.

Financial autonomy
56.66% 2024
2022
2023
2024
Q1: 24.8%
Med: 50.27%
Q3: 69.09%
Good -11 pts over 3 years

In 2024, the financial autonomy of LABORATOIRE 7 MED (56.7%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.

Repayment capacity
-0.31 years 2023
2022
2023
Q1: 0.0 years
Med: 0.51 years
Q3: 2.03 years
Excellent -50 pts over 2 years

In 2023, the repayment capacity of LABORATOIRE 7 MED (-0.31) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 257.08. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2024) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

257.083

Liquidity indicators evolution
LABORATOIRE 7 MED

Sector positioning

Liquidity ratio
257.08 2024
2022
2023
2024
Q1: 159.64
Med: 253.69
Q3: 429.69
Good -14 pts over 3 years

In 2024, the liquidity ratio of LABORATOIRE 7 MED (257.08) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.

Interest coverage
-0.12x 2023
2022
2023
Q1: 0.0x
Med: 0.81x
Q3: 4.71x
Average -24 pts over 2 years

In 2023, the interest coverage of LABORATOIRE 7 MED (-0.1x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2024) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2024) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2024) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2024) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
LABORATOIRE 7 MED

Positioning of LABORATOIRE 7 MED in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare LABORATOIRE 7 MED with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire

Frequently asked questions about LABORATOIRE 7 MED

What is the revenue of LABORATOIRE 7 MED ?

The revenue of LABORATOIRE 7 MED in 2023 is 2.7 M€.

Is LABORATOIRE 7 MED profitable?

LABORATOIRE 7 MED recorded a net loss in 2024.

Where is the headquarters of LABORATOIRE 7 MED ?

The headquarters of LABORATOIRE 7 MED is located in LORIOL-SUR-DROME (26270), in the department Drome.

Where to find the tax return of LABORATOIRE 7 MED ?

The tax return of LABORATOIRE 7 MED is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does LABORATOIRE 7 MED operate?

LABORATOIRE 7 MED operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.